Korea Shipbuilding & Offshore Engineering Co. has received a 607.2 billion-won order from an unidentified Panamanian shipper to build three liquefied natural gas (LNG) ships.
Hyundai Samho Heavy Industries Co., one of the holding company's shipbuilding affiliates, will build the LNG carriers by September 2024.
The two other shipbuilding affiliates of Korea Shipbuilding & Offshore Engineering Co. are Hyundai Heavy Industries Co. and Hyundai Mipo Dockyard Co.
On Monday, Korea Shipbuilding received 10 orders from European shipping companies worth 1.2 trillion won to build four large 132,000-TEU containers, three LNG carriers, two midsize 40,000-square-meter LPG carriers, and one small 17,000-ton petrochemical carrier.
Korea Shipbuilding also struck a 1-trillion-won deal with shippers in Europe, Bermuda, and Asia last week to build four 174,000-square-meter LNG carriers and two 318,000-ton very large crude carriers.
So far, the three shipyards have secured $9.4 billion worth of orders, achieving 85 percent of its $11 billion order target.


Shein Targets $26B-$27B Valuation for Hong Kong IPO
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
SK Hynix Shares Surge on Record $28.6 Billion Buyback
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Google to Move All Pixel Production Out of China by 2027
REPAY Stock Rises After Visa Platform Connect Collaboration
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
OpenAI Tightens AI Safety Monitoring After Security Incidents
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 



